Amundi Sells 75,993 Shares of UiPath, Inc. $PATH

Key Points

• Amundi cut its UiPath stake by 20.7%, selling 75,993 shares in the second quarter and retaining 290,463 shares valued at approximately $3.16 million.
• UiPath reported quarterly revenue of $410.26 million, up 13.3% year over year and above expectations, while earnings of $0.15 per share matched analyst estimates.
• CEO Daniel Dines sold 1.4 million shares for approximately $22.5 million. Analysts maintain a consensus “Hold” rating with an average price target of $16.75, compared with the stock’s reported price of $13.76.

Amundi lessened its stake in UiPath, Inc. (NYSE:PATH - Free Report) by 20.7% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 290,463 shares of the company's stock after selling 75,993 shares during the quarter. Amundi owned about 0.06% of UiPath worth $3,157,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Trifecta Capital Advisors LLC acquired a new stake in shares of UiPath in the second quarter valued at approximately $27,000. Atlas Capital Advisors Inc. acquired a new position in UiPath during the 4th quarter worth $37,000. AdvisorNet Financial Inc lifted its holdings in UiPath by 750.0% during the 1st quarter. AdvisorNet Financial Inc now owns 3,400 shares of the company's stock worth $38,000 after buying an additional 3,000 shares in the last quarter. REAP Financial Group LLC bought a new position in UiPath in the 4th quarter valued at $44,000. Finally, Global Retirement Partners LLC bought a new position in UiPath in the 2nd quarter valued at $57,000. 62.50% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, CEO Daniel Dines sold 1,402,347 shares of UiPath stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $16.07, for a total transaction of $22,535,716.29. Following the transaction, the chief executive officer directly owned 26,491,238 shares of the company's stock, valued at $425,714,194.66. This trade represents a 5.03% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 22.44% of the stock is owned by insiders.

UiPath Stock Down 0.8%

NYSE:PATH opened at $13.76 on Friday. UiPath, Inc. has a 12-month low of $9.20 and a 12-month high of $19.84. The firm has a market capitalization of $7.13 billion, a P/E ratio of 20.53, a P/E/G ratio of 1.35 and a beta of 1.02. The stock's fifty day simple moving average is $14.20 and its 200-day simple moving average is $12.05.

UiPath (NYSE:PATH - Get Free Report) last released its quarterly earnings data on Thursday, September 3rd. The company reported $0.15 EPS for the quarter, meeting analysts' consensus estimates of $0.15. UiPath had a return on equity of 9.70% and a net margin of 21.03%.The business had revenue of $410.26 million during the quarter, compared to the consensus estimate of $397.77 million. During the same quarter in the prior year, the company posted $0.15 earnings per share. The firm's revenue was up 13.3% on a year-over-year basis. As a group, equities research analysts expect that UiPath, Inc. will post 0.47 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. TD Cowen boosted their target price on UiPath from $13.00 to $16.00 and gave the stock a "hold" rating in a research report on Friday, September 4th. DA Davidson raised their price target on UiPath from $12.00 to $16.00 and gave the company a "neutral" rating in a report on Friday, September 4th. BMO Capital Markets lifted their price objective on UiPath from $13.00 to $18.00 and gave the stock a "market perform" rating in a research report on Friday, September 4th. Wall Street Zen cut UiPath from a "buy" rating to a "hold" rating in a report on Saturday, May 30th. Finally, UBS Group set a $16.00 price objective on UiPath in a report on Friday, September 4th. Three investment analysts have rated the stock with a Buy rating, sixteen have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of "Hold" and an average target price of $16.75.

UiPath Company Profile

UiPath Inc NYSE: PATH develops enterprise automation software designed to help organizations automate repetitive, rules-based and increasingly complex business processes. Its platform combines robotic process automation (RPA), artificial intelligence, workflow orchestration and process intelligence to support automation across areas such as finance, customer service, human resources, information technology and operations.

The UiPath Platform includes tools for discovering and analyzing business processes, building and managing software robots, processing documents, testing applications and coordinating automated workflows.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.